Do you want to read an article? Please log in or register.
Enzalutamide in castration-resistant prostate cancer patients with visceral disease in the liver and/or lung: Outcomes from the randomized controlled phase 3 AFFIRM trial
Gastrointestinal CancerGenitourinary Cancer